Wu Tsai Neurosciences Institute

The Wu Tsai Neurosciences Institute and Stanford Data Science are collaborating to better understand the surge of data generated from large-scale neuron recordings and enhanced fMRI technology.

Harnessing the power of music to synchronize brain waves, neuroscientists have enhanced the effectiveness of a promising approach to brain research and the treatment of neuropsychiatric disorders.

Stanford researchers reviewed over 400 therapy evaluations and discovered a crucial mismatch: Mouse studies test disease prevention, while human trials test treatment of existing disease.

An interdisciplinary team working on balls of human neurons called organoids wanted to scale up their efforts and take on important new questions. The solution was all around them.

New findings suggest the same brain systems that guide animals to rewards may be weakened in dementia and intensified in addiction.

The CARDIAC-PND study is one of the first to monitor brain resilience in living people, capturing how older adults respond and adapt to the stress of surgery – and why some go on to develop dementia while others remain cognitively strong.

Four teams have received funding to advance research on healthy brain aging and neurodegenerative diseases, including a new theory on Parkinson’s disease and predicting aging trajectories.

Knight Initiative researchers have discovered a biomarker in spinal fluid that could help forecast the progression of Alzheimer’s and improve clinical trials.

A new study unravels the complex interplay between innate brain structure and experience-dependent development. The findings could lead to earlier diagnosis and intervention for developmental disorders.

Research supported by a Knight Initiative Catalyst Grant explores whether targeting pathways related to the brain’s “chill-out” system could restore youthful resilience and improve cognitive function.